The CRISPR (clustered regularly interspaced short palindromic repeats) mechanism allows bacteria to adaptively defend against phages by acquiring short genomic sequences (spacers) that target specific sequences in the viral genome. We propose a population dynamical model where immunity can be both acquired and lost. The model predicts regimes where bacterial and phage populations can co-exist, others where the populations oscillate, and still others where one population is driven to extinction. Our model considers two key parameters: (1) ease of acquisition and (2) spacer effectiveness in conferring immunity. Analytical calculations and numerical simulations show that if spacers differ mainly in ease of acquisition, or if the probability of acquiring them is sufficiently high, bacteria develop a diverse population of spacers. On the other hand, if spacers differ mainly in their effectiveness, their final distribution will be highly peaked, akin to a "winner-take-all" scenario, leading to a specialized spacer distribution. Bacteria can interpolate between these limiting behaviors by actively tuning their overall acquisition rate.
Bacteria and archaea can combat viral infections using innate mechanisms (e.g., abortive infection, surface exclusion and restriction modification systems) that are not specific to particular threats [1] [2] [3] . Some species also exhibit an adaptive immune system based on CRISPR (clustered regularly interspaced short palindromic repeats) interference, which allows bacteria to specifically target and cleave exogenous genetic material from previously encountered phages and other genetic elements [4] [5] [6] [7] . The system works by incorporating short (30-70 bp) sequences, dubbed "spacers", into the bacterial genome, in between repeated CRISPR elements (Fig. 1 ). The spacers are acquired from the "protospacer" regions in the genome of infecting phage. CRISPR Type I and II require the presence of a "protospacer adjacent motif" (PAM) upstream of a protospacer for recognition by the CRISPR proteins [8] . The PAM sequence is thought to play a role in the avoidance of auto-immune targeting [9] . While the PAM and the first few nucleotides of the protospacer (the "seed" region) need to match almost perfectly for CRISPR interference [6] , there is significant tolerance to mutations in the rest of the spacer [10] .
Over the whole viral genome, there can be tens or hundreds of protospacers, and the way in which the CRISPR acquisition mechanism selects between these is not fully understood [11] . Experiments show that after several hours of exposure of bacteria to phage, different spacers occur with different frequencies, with a handful being much more abundant [12] . This difference could be driven by a bias in acquisition-some spacers might be easier to acquire by the CRISPR proteins than others [13] . Or perhaps some protospacers are more conserved in the viral population, and thus more abundant and more likely to be acquired. Another possibility is * Equal contribution indicated.
FIG. 1. Schematic of the CRISPR acquisition and interference mechanism. PAM stands for protospacer adjacent motif, a short sequence necessary for protospacer recognition by the Cas proteins.
that some spacers might be more effective than others at clearing viral infections and so provide a selective advantage for the host [4, 10] . Finally, the acquisition of some spacers might be "primed" by the presence of other spacers in the CRISPR locus [6, 11, 14, 15] .
We construct a population dynamical model for bacteria that use CRISPR-based immunity to defend against phage. We compare two limits, where different spacers are acquired at different rates, vs. where they provide different advantages to the host. Spacers may lead to different growth rates or survival rates upon infection. We derive analytical results for the asymptotic spacer distribution at large times, and show that the spacer-effectiveness model favors a peaked distribution of spacers while the spacer-acquisition model favors a more diverse distribution. Higher rates of spacer acquisition also lead to higher diversity. We expect that greater spacer diversity will be important for defending against a mutating phage landscape, while a peaked spacer distribution will confer stronger immunity against a specific threat. Our model predicts that bacteria can negotiate this tradeoff by controlling the overall rate at which spacers are acquired, i.e., by modifying the expression of the cas proteins, necessary for acquisition [6] .
I. RESULTS
We consider bacteria that start with a CRISPR cassette containing only one repeat, a scenario that has been proven functional in vivo [16] . Most bacteria only acquire a single spacer in lab experiments that last a day [17] and older spacers do not typically match the phage used in the experiments. Hence, in thinking about the results of such experiments, we will focus our attention on bacteria that contain at most one spacer in their CRISPR locus. Of course, many types of spacers will be acquired across the population even though each bacterial cell contains at most one in this scenario [12, 18] .
Here we propose a model of bacteria and phage dynamics. We first study the case of a single protospacer to understand conditions under which host-virus coexistence is possible. Then we generalize the results to the case of many protospacers where acquisition rate and effectiveness can depend on the type.
A. Extinction versus coexistence with one type of spacer
To set the stage, we will first explain the dynamics of a model where viruses present a single protospacer. In this case, all immune bacteria have the same spacer. We will assume logistic growth of the bacteria [19] . The relevant processes are sketched in Fig. 2 and, assuming a well-mixed population, can be translated into a set of ordinary differential equations:
Here, n 0 is the number of "wild type" bacteria that do not contain any spacers, n 1 is the number of "spacer enhanced" bacteria that have acquired the spacer, I 0 is the number of wild-type infected bacteria, and I 1 is the number of spacer enhanced but infected bacteria (which is possible because spacers do not provide perfect immunity). The sizes of the bacterial and phage populations are n and v respectively. The first term in the first two equations in (1) describes logistic growth of the bacteria with maximum growth rates f i and a carrying capacity K. These equations allow for the possibility that spacer enhanced bacteria may grow at a different rate than the wild type because of possible spacer toxicity due to auto-immune interactions or due to increased metabolic rate arising from expression of CRISPR (Cas) proteins and/or CRISPR RNA (crRNA). However, there is evidence [12, 20] that these growth rate differences are small so that r = f 1 /f 0 ∼ 1.
We also assume that spacers can be lost at a rate κ (second term in the first and second equations) allowing bacteria to revert to wild type [20, 21] . Bacteria become infected with different rates depending on their typewild type are always infected if they encounter phage, but spacer enhanced bacteria may evade infection. Taking g to be the encounter rate, wild type are infected at a rate g while spacer enhanced bacteria are infected at a rate ηg where η < 1 (third terms of the first and second equations). Finally, infected wild-type bacteria that survive and acquire a spacer with probability α (last term in the second equation). We can imagine that this acquisition occurs in the course of an infection that is unsuccessful because the phage is ineffective or because of innate immune mechanisms, while nevertheless allowing the bacterial cell access to genetic material of the phage. We are neglecting the possibility that spacers might also be acquired via horizontal gene transfer without an infection.
The dynamics of the infected bacteria is given in the third and fourth equations in (1) . We assume that infected bacteria do not divide. So the number of infected bacteria grows only because of new infections (first terms in the equations), and declines due to lysis or successful defense followed by acquisition of spacers (second term). The lysis rate µ depends on properties of the phage including the burst factor b (i.e., the number of viral particles produced before lysis). In detail, there is a delay between infection and lysis because it takes some time for the virus to reproduce. We are mimicking this delay here by including a timescale 1/µ for lysis [22, 23] .
Finally, the last equation describes the dynamics of free phage. The first two terms model viral replication. Phage that duplicate in infected bacteria produce b new copies after cell lysis. The first term describes this process in infected wild type bacteria that do not acquire a spacer and become immune. The second term describes the lysis of bacteria that were infected despite having a spacer. We could imagine that small number of spacer enhanced bacteria that become infected then become resistant again, perhaps by acquiring a second spacer. We neglect this because the effect is small for two reasonsacquisition is rare, α 1, and because we assume that the spacer is effective, η 1, such that I 1 is small. We can also write an equation for the total number of bacteria, n = n 0 + n 1 + I 0 + I 1 :
where we introduced the notation r = f 1 /f 0 . The total number of bacteria is a useful quantity, since optical density measurements can assess it in real time.
The numerical solution of our single-spacer population dynamics model is presented in Fig. 3 for different parameter choices. In all cases, the bacterial population grows initially because infected bacteria do not die instantly. If the viral load is high, most bacteria are quickly infected and growth starts slowing down since infected bacteria cannot duplicate. After a lag of order 1/µ the population declines due to lysis. If the viral load is low (gv(0) < f 0 ), the division of healthy bacteria dominates the death of infected ones, until the viral population released by lysis becomes large enough to infect a substantial fraction of the bacteria.
Some infected bacteria acquire the spacer that confers partial immunity from the phage. During every encounter between a bacterial cell and a virus, there is a probability η that the spacer will be ineffective. Thus the expected increase in the number of viral particles following an encounter is bη − 1 where b is the viral burst size following lysis of an infected cell. If η > 1/b, the viral growth cannot be stopped by CRISPR immunity and the bacteria are eventually overwhelmed by the infection. Thus whenever the virus has a high burst factor, only a population with an almost perfect spacer (η < 1/b 1) is able to survive infection.
The viral concentration has a more complex dynamics-it typically reaches a maximum, then falls due to CRISPR interference, and starts oscillating at a lower value ( Fig. 3 ). The initial rise of the viral population occurs because of successful infections of the wild-type bacteria. But then, the bacteria which have acquired effective spacers grow exponentially fast, virtually unaffected by the presence of the virus. Since the virus is adsorbed by immune bacteria, but are cleaved by CRISPR and cannot duplicate, the viral population declines exponentially. However, as the population of spacer-enhanced bacteria rises, so does the population of wild type, because of the constant rate of spacer loss. This starts a new growth period for the virus, leading to the oscillations seen in simulations. When spacer effectiveness is low, the virus can still have some success infecting spacerenhanced bacteria, and the oscillations are damped. It would be interesting to test whether large oscillations in the viral concentration can be seen in experiments to see if these are compatible with measured estimates of the rate of spacer loss κ in the context of our model [20, 24] .
Varying the growth rate of the bacteria with CRISPR relative to the wild type has a strong effect on the length of the initial lysis phase and the delay before exponential decay sets in. In contrast, a lower effectiveness of the CRISPR spacer (i.e., larger η; green line in Fig. 3 ) leads to a higher minimum value for the viral population and weaker oscillations. This could potentially be used to disentangle the effects of growth rate and CRISPR interference on the dynamics.
After a transient period, the dynamics will settle into a stationary state. The transient is shorter if the spacer enhanced growth rate f 1 is high, or if the failure probability of the spacer η is low ( Fig. 3 ). Depending on the choice of initial values and the parameters, there are different steady states. If spacers are never lost (κ = 0), we found numerically that a stable solution occurs when viruses go extinct and infections cease (v = 0, I 0,1 = 0). In this case, the total number of bacteria becomes stationary by reaching capacity (n = K), which can only happen when the spacer is sufficiently effective (η < 1/b). Otherwise bacteria go extinct first (n = 0) and then the virus persists stably.
A more interesting scenario occurs when spacers can be lost (κ = 0). In this case co-existence of bacteria and virus (n > 0 and v > 0) becomes possible (see SI for an analytic derivation). In this case, the bacteria cannot reach full capacity at steady state-we write n = K(1 − F) where the factor F = 0 represents the fraction of unused capacity. The general expression for F is given in the SI, and simplifies when the wild type and spacer enhanced bacteria have the same growth rate (r = 1) to
.
(3) Fig. 3 shows the dependence of F on the failure probability of the spacer (η). We see that even if the spacer is perfect (η = 0) the steady state bacterial population is less than capacity (F > 0). These equations are valid when F < 1-this is only possible if the spacer failure shows the dynamics of the phage population. In both panels, the time is shown in units of the inverse growth rate of wild type bacteria (1/f0). Parameters are chosen to illustrate the coexistence phase and damped oscillations in the viral population: the acquisition probability is α = 10 −4 , the burst size upon lysis is b = 100. All rates are measured in units of the wild type growth rate f0: the adsorption rate is g/f0 = 10 −4 , the lysis rate of infected bacteria is µ/f0 = 1, and the spacer loss rate is κ/f0 = 2×10 −3 . The spacer failure probability (η) and growth rate ratio f1/f0 are varied. The bacterial population has a bottleneck after lysis of the bacteria infected by the initial injection of phage, and then recovers due to CRISPR immunity. Accordingly, the viral population reaches a peak when the first bacteria burst, and drops after immunity is acquired. A higher failure rate η allows a higher steady state phage population, but oscillations can arise because bacteria can lose spacers (see text). (Panel c) shows the fraction of unused capacity at steady state (Eq. (3)) as a function of the product of failure probability and burst size (ηb) for a variety of acquisition probabilities (α). In the plots, the burst size upon lysis is b = 100, the growth rate ratio is f1/f0 = 1, and the spacer loss rate is κ/f0 = 10 −2 . We see that the fraction of unused capacity diverges as the the failure probability approaches the critical value ηc ≈ 1/b (Eq. (4)) where CRISPR immunity becomes ineffective. The fraction of unused capacity decreases linearly with the acquisition probability following Eq. (3).
probability (η) is smaller than a critical value (η c ), where
This co-existence phase has been found in experiments [17] where the bacterial population reaches a maximum that is "phage" limited like in our model. In the co-existence phase, the wild type persists at steady state, as observed in experiments [17] . In our model, the ratio of spacer-enhanced and wild-type bac-teria is
This ratio does not depend on the growth rates of two types of bacteria (f 1 vs. f 0 ). So, given knowledge of the burst size b upon lysis, the population ratio in Eq. (5) gives a constraint relating the spacer acquisition probability α and the spacer failure probability η. Thus, in an experiment where phage are introduced in a well mixed population of wild type and spacer enhanced bacteria, Eq. (5) presents a way of measuring the effectiveness of a spacer, provided the machinery for acquisition of additional spacers is disabled (α = 0) (e.g., by removing specific Cas proteins) [4, 25] .
In previous models, coexistence of bacteria and phage was achieved by hypothesizing the existence of a product of phage replication that specifically affects spacerenhanced bacteria compared to wild type [17] . Here we showed that coexistence is obtained more simply if bacteria can lose spacers, a phenomenon that has been observed experimentally [20, 21] . Our model also reproduces an effect observed by [17] , namely that the steady state bacterial population is reduced by the presence of virus. While this may seem intuitive, previous population dynamics models have not reproduced this finding, which depends critically in our model on the rate of spacer loss.
B. Effectiveness versus acquisition rate from multiple spacers
Typically the genome of a given bacteriophage contains several protospacers as indicated by the occurrence of multiple PAMs. Even though in the short term each bacterial cell can acquire only one spacer type, at the level of the whole population many types of spacers will be acquired, corresponding to the different viral protospacers. Experiments show that the frequencies with which different spacers occur in the population are highly nonuniform, with a few spacer types dominating [12] . This could happen either because some spacers are easier to acquire than others, or because they are more effective at defending against the phage.
We can generalize the population dynamics in (1) to the more general case of N spacer types. Following experimental evidence [20] we assume that all bacteria, with or without spacers, grow at similar rates (f )-the effect of having different growth rates is analyzed in the Supplementary Material. We take spacer i to have acquisition probability α i and failure probability η i . The dynamical equations describing the bacterial and viral populations become
where n i and I i are the numbers of healthy and infected bacteria with spacer type i, and α = N i=1 α i < 1, since the probability that infected wild type bacteria survive and acquire a spacer is smaller than 1. The total number of bacteria is governed by the equation
As before, the most interesting case is when the virus and bacteria co-exist. The bacteria do not generally fill their capacity when this happens. The fraction of unused capacity (F = 1 − n/K) can be characterized using the average failure probability (η):
Bacteria and phage co-
. This is an implicit expression becauseη itself depends on the distribution of bacteria with different spacers. The co-existence solution can be computed analytically
We see that the spacer distribution depends on the acquisition and failure probabilities (α i and η i ). As discussed in the single spacer case, the third equation gives a way to measure the average failure probability (η) of spacers by turning off the acquisition machinery after a diverse population of spacers is acquired [4, 25] . (This remains true even if the spacer also affects the growth rate-see Supplementary Information.) Given knowledge of the spacer failure probabilities (η i ) from single spacer experiments, we can also obtain the acquisition probabilities (α i ) by When the acquisition probability is constant (green curve) the population fraction of a spacer is determined by its failure probability. If the acquisition probability is anticorrelated with the failure probability (blue curve), effective spacers are also more likely to be acquired and this skews the distribution of spacers even further. If the acquisition probability is positively correlated with the failure probability (red curve), more effective spacers are less likely to be acquired. Despite this we see that the most effective spacer still dominates in the population.
measuring the ratio of spacer enhanced to wild type bacteria (n i /n 0 ) and using the second equation in (9) .
The second equation in (9) also allows us to make qualitative predictions about mechanisms affecting the steady state spacer distribution. First, the steady state abundance of each spacer type is proportional to its probability of acquisition (α i ). This implies that, if all else is kept fixed, a large difference in abundance can only come from a large difference in acquisition probability (see Fig.  4a ).
In contrast, the dependence on the failure probability (η i ) appears in the denominator, so that large variations in abundance can follow from even modest differences in effectiveness (Fig. 4b ). When spacers differ in both acquisition and failure probability, the shape of the distribution is controlled mostly by the differences in effectiveness, with acquisition probability playing a secondary role (Fig. 4c ). This suggests that the distribution of spacers observed in experiments, with a few spacer types being much more abundant than the others [12] , is likely indicative of differences in the effectiveness of these spacers, rather than in their ease of acquisition.
Our model also predicts that the overall acquisition probability (α) is important for controlling the shape of the spacer distribution. Large acquisition probabilities tend to flatten the distribution, leading to highly diverse bacterial populations, while smaller acquisition probabilities allow the most effective spacers to take over (Fig.  4b) . This raises the possibility that the overall spacer acquisition rate of bacteria could be under evolutionary selection pressure as a means of trading off the benefits conferred by diversity in dealing with an open environment against the benefits of specificity in combatting immediate threats. This idea could be tested in directed evolution experiments where bacteria are grown in artificial environments with less or more variability in the phage population.
II. CONCLUSIONS
The CRISPR mechanism in bacteria is an exciting emerging arena for the study of the dynamics of adaptive immunity. Recent theoretical work has explored the coevolution of bacteria and phage [17, 26, 27] . For example, Levin et al. [17] modeled several iterations of an evolutionary arms race in which bacteria become immune to phage by acquiring spacers, and the viral population escapes by mutation. Han et al. [26] studied coevolution in a population dynamics model in which there are several viral strains, each presenting a single protospacer modeled by a short bit string. Childs et al. [27] also used a population dynamics model to study the long-term coevolution of bacteria and phage. In their model, bacteria can have multiple spacers and viruses can have multiple protospacers, and undergo mutations.
Our goal has been to model the effect of different properties of the spacers, such as their ease of acquisition and effectiveness, on their abundance at steady state in a setting where there is only enough time to acquire a single spacer. The reason for the latter restriction is that it leads to a more easily interpretable experimental setting. We aimed for a model with the minimal interactions that could explain existing observations, such as an over-abundance of a small number of spacers compared to the rest and the co-existence of phage and bacteria [12, 17, 18] . We are specifically interested in the possibility that encounters with a single phage could lead to the acquisition of diverse spacers, a phenomenon that was not included in [26] . Likewise, Levin et al. [17] did not explicitly model the spacer types and hence could not address their diversity. Furthermore, their model captured co-existence by postulating a as-yet-undetected lysis product from wild type bacteria that harms spacer enhanced ones. We showed above that co-existence can also be obtained simply by including spacer loss, which has been experimentally observed [20, 24, 28] . Co-existence was also addressed by Haerter el al. [29] by exploiting spatial heterogeneity, but, as we showed, this phenomenon can also occur in well-mixed populations. Finally, Weinberger et al. [30] used a population genetic model in which the sizes of the bacterial and phage populations are fixed, thus precluding study of the conditions required for co-existence. The model also did not consider potential differences in efficacy of spacers.
Spacer diversity was addressed in He et al. [31] and Han et al. [26] , but they focused on the way in which diversity depends on position within the CRISPR locus as opposed to the properties of spacers that influence their relative abundance. Childs et al. [27] were also interested in spacer diversity but assumed that all spacers have similar acquisition rates and effectiveness, while we have sought precisely to understand how differences in these parameters affect diversity.
Our model makes several predictions that can be subjected to experimental test. First, spacer loss [20, 24, 28] is a very simple mechanism that allows for co-existence of bacteria and phage. Direct measurements of the rates of spacer loss may be possible, and would furnish an immediate test of our model. Alternatively, our model provides a framework for an indirect measurement of the spacer loss rate. Specifically, this rate is proportional to the viral population and the fraction of unused capacity at steady state. When the probability of spacer loss is small, our formalism predicts a correspondingly small average viral population. Of course, the population in any given experiment experiences fluctuations which could lead to extinction. An interesting avenue for future work is to include such stochasticity, which would then predict the typical time-scale for viral extinction corresponding to a given probability of spacer loss. This time-scale can be compared with experimental observations [32] .
The effectiveness parameters in our model could be extracted in experiments where bacteria are engineered to have specific spacers [33] and acquisition is disabled [4, 25] . In principle the acquisition parameters could be measured by freezing bacterial populations soon after an infection, although initial conditions would require careful control. Given these parameters, a comparison between the measured and predicted dynamics would constitute a test of our model. Alternatively, our model could be fit to measured dynamics to extract the parameters and then tested by comparing with the steady state.
When multiple protospacers are available we showed that the acquisition probability linearly affects the steady state spacer distribution, while the proportion of more effective spacers is magnified by the dynamics. Thus, a highly peaked spacer distribution as seen in some studies [12] is more likely to occur because of differences in effectiveness if protospacers are acquired with roughly equal probabilities. In fact, it does seem that some genomic sequences are acquired more frequently than others [6, 13] . While the mechanism for this enhancement has not been fully clarified, one possibility is that the more commonly acquired sequences are simply those that are less prone to mutation in the viral genome. This could be tested by sequencing the virus together with the CRISPR-cassettes in a co-evolving population of bacteria and phage. This mechanism for enhancing acquisition probability of some spacers is readily incorporated in our model.
Various extensions of our model are possible. For example, in describing longer timescale experiments we can include the fact that CRISPR cassettes can contain many spacers [31] . Furthermore, we could include the possibility of "priming" where the presence of some spacers increases the probability of acquiring others [6] . Such an effect would introduce correlations between different spacer populations n i and n j that can be tested experimentally.
Our model showed that high acquisition probabilities will lead to greater diversity in the spacer distribution, while strong selection will tend to homogenize the population of spacers in favor of the most effective one for the current threat. This suggests that bacteria should adapt the overall spacer acquisition rate to the amount of viral diversity in their environment, perhaps by transcriptional regulation of the cas genes. Given an appropriate fitness function and viral landscape our modeling framework could be used to predict the optimal acquisition rate. We numerically integrated our population dynamics equations using custom code written in C. The order of magnitude of the burst size b, carrying capacity K and growth rate f were taken from [1] , the spacer loss rate κ was estimated from [2] , and the spacer failure probability η and acquisition probability α were variables that we scanned over. We took the death rate µ of infected bacteria to be comparable to the growth rate f . To estimate the order of magnitude of the phage adsorption rate g we used a simple argument based on diffusion. Because of the large difference in size, we approximate phage particles with points and focus on a single bacterial cell, modeled as a perfectly absorbing sphere of radius R. Fick's second law, ∂ t c = D∆c, can be used to calculate the concentration profile of phage around the bacteria at stationarity, leading to c(r) = c p 1 − R r , where c p is the concentration of phage far away from bacteria. Fick's first law then gives us the flux at the sphere, whose integral gives the rate at which phage are absorbed, 4πDc p R, where D is the diffusion coefficient. Using Einstein's relation D = k B T 6πηrv to estimate the diffusion coefficient (with η the dynamic viscosity of the medium and r v the size of the virus), we get that an estimate for g is
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where V is the experimental volume, which only appears here because we defined g in terms of particle numbers instead of concentrations. Using V ∼ 1 µL, η = 8 × 10 −4 Pa · s (for water at 30 • ), T = 300 K, R ∼ 1 µm, r v ∼ 0.1 µm, we get g ∼ 10 −4 hour −1 . This is very close to experimental values observed in in vitro experiments of bacteria and phage [3] .
II. DETAILED DYNAMICS AND STEADY STATE WITH ONE TYPE OF SPACER
A. Transient behavior
In addition to the numerical studies presented in the main text, some aspects of the dynamics of our model can be described analytically. This allows us to get further insights into general features of the solutions and how these features depend on the parameters.
Consider the initial trend in the bacterial population. At the time of inoculation, the population is entirely wild type, so n 1 (0) = 0, and there are no infected bacteria, I 0 (0) = 0, I 1 (0) = 0. The total bacterial population is n(0) ≡ n 0 (0) < K. From eq. [2] in the main text, this implies thatṅ(0) > 0, i.e., the bacteria always start off with growth, which is a result of the latency between viral infection and death. However, we expect this growth to be short lived: after a time of order µ −1 , the infected cells should start dying and the bacterial population should go down. It turns out that growth can sometimes last much longer than that, as shown below.
Suppose we have t 1/µ and, for simplicity, assume n 0 (0) K; from the system of equations [1] in the main text we get n 0 = n 0 (0) + f 0 − gv(0) n 0 (0) t + O(t 2 ) ,
Similarly n 1 = O(t 2 ) and I 1 = O(t 2 ), implying thaṫ
If gv(0) > f 0 then growth ends in a time t p = 1
assuming that the acquisition probability α is small. Conversely, if
the initial growth of the wild type bacteria continues past the initial latency time t = 1/µ. This prediction of the model can be tested via optical density measurements. Of course, past this time, the approximations we made above no longer hold; eventually the wild type population will decline, being overtaken by the virus, and the bacteria will go through a bottleneck; see Fig. 3 of the main text. Recovery from this bottleneck is due to CRISPR spacer acquisition.
B. Steady state solutions and stability analysis a. Coexistence solution: v = 0 and n = 0. The steady state solutions for the system in eq. [1] from the main text are obtained by setting all the derivatives to zero. Solving the equations for the number of infected bacteria and plugging these into the equation for the viral dynamics, we get
where we assumed v = 0. Since I i , n i , and v are population numbers, they must be non-negative. From eq. (6) above, this requires that bη < 1 and bα < b − 1 [4] . If these conditions are not met, the co-existence solution is not feasible, and we get either n i = I i = 0 or v = 0.
The remaining steady state values can be obtained after some tedious but straightforward algebra:
where we see that the virus concentration at steady state is proportional to the rate of spacer loss (κ). Here the notation F r is used to emphasize the fact that we allow for different growth rates for wild type and spacer enhanced bacteria.
Compared to the value from eq. [3] in the main text, the fraction of unused capacity (F) changes when the wild type and spacer enhanced growth rates are unequal. The magnitude of the change obeys Other parameters are chosen similar to the main text: the growth rates of spacer enhanced and wild type bacteria are equal (r = 1), the phage adsorption rate is given by g/f0 = 10 −4 , and the death rate of infected bacteria is given by µ/f0 = 1. The initial population is all wild type, and the initial multiplicity of infection (MOI; v/n) is 10.
In the left panel, the rate of spacer loss is kept fixed at κ/f0 = 0.001. In the right panel, the acquisition probability is kept fixed at α = 0.003. We see that the oscillations in the wild type bacteria and viral populations are more strongly damped for large spacer loss rates. where = r − 1.
The positivity of n 0 and n 1 also implies that F r < 1. This translates into a more stringent condition on the failure probability of the spacer (η). For bacteria to be able to resist infection and for the co-existence solution to be feasible, we need η < η c , where the critical failure probability is
This gives the next couple of terms in the expansion in eq. [4] in the main text. We write this as an expansion in = r − 1 because experiments suggest that differences between the growth rates of wild type and spacer enhanced bacteria are small.
Another interesting limit to consider is when the burst size b is very large, which is the case for typical viruses. When b → ∞, the product between the burst size and the critical failure probability simplifies to
This means that, apart from being inversely proportional to the burst factor, the critical failure rate at large b only depends on the rate of spacer loss (κ), the acquisition probability (α), and the growth rate of the spacer enhanced bacteria (f 1 ). In particular, it does not depend on the wild type growth rate. A numerical study shows that when the coexistence solution exists (η < η c ), it is also stable for a wide range of parameters. Altering the spacer acquisition probability (α), the rate of spacer loss (κ), or the failure probability (η) in a wide range does not preclude the coexistence state, although it can lead to significant changes in the population dynamics (see SI Figures 1 and 2) . Interestingly, the dynamics of the total number of bacteria (n) is almost insensitive to the rate of spacer loss (κ). The viral population, and therefore also the population of infected bacteria, are much more strongly affected by changes in the rate of spacer loss. Frequent loss of spacers leads to a stronger damping and shorter period for the oscillations in the viral population, while less frequent loss greatly enhances the amplitude of these oscillations. Other parameters are chosen similar to the main text: the growth rates of spacer enhanced and wild type bacteria are equal (r = 1), the phage adsorption rate is given by g/f0 = 10 −4 , the death rate of infected bacteria is given by µ/f0 = 1, and the rate of spacer loss is κ/f0 = 0.002. The initial population is all wild type, and the initial multiplicity of infection (MOI; v/n) is 10.
The ability to acquire spacers has a large effect on the early dynamics of the bacterial population, while not greatly affecting the viral dynamics. Lower acquisition probabilities lead to a tighter bottleneck for the bacteria, as they require a longer time to gain the CRISPR immunity that they need to fight viral infection.
The spacer failure probability (η) does not affect the total bacterial population too much, but has a large effect on the steady state population of phage and wild type bacteria, as well as on the transient dynamics leading to the steady state. More effective spacers lead to larger numbers of wild type bacteria and fewer viruses, shorter transients, and more oscillatory dynamics. In contrast, bacteria with less effective spacers (larger η) can take a long time to reach steady state, don't seem to exhibit oscillations, and lead to fewer wild type bacteria and more viruses.
When stochastic effects are taken into consideration, random fluctuations could lead to extinction of either bacteria or phage when these go through bottlenecks. Thus, smaller acquisition probabilities lead to higher chances of bacterial extinction, while smaller rates of spacer loss would be dangerous for the phage's survival. Very effective spacers also increase the oscillations in the viral dynamics, while also lowering the steady state viral population, so they too can contribute to viral extinction.
b. Virus extinction v = 0. When the virus goes extinct (v = 0), the steady state populations of wild type and spacer enhanced bacteria can depend on the initial conditions. We can gain some intuition into this case by considering a model in which the virus has already gone extinct; thus, v = 0 and I 0 = I 1 = 0. In this case, the system of equations simplifies to
where we also assumed that the wild type and spacer enhanced growth rates are equal (f 1 = f 0 ). The solution can be found analytically: Figure 3 . Dynamics of the fraction of spacer enhanced bacteria in absence of virus, when spacer enhanced and wild type growth rates are different (r = f1/f0 = 1). For comparison, we show the analytical solution reported in eq. (12) for the special case r = 1 (black line). The long-term decay of the spacer-enhanced population relative to wild type is simply due to spacer loss in the absence of virus. In the inset we emphasize the exponential decays for longer time scales by using a log scale.
where t 0 is the initial time and n(t 0 ) and n 1 (t 0 ) are the initial total population of bacteria and the initial population of spacer enhanced bacteria, respectively. In the long term limit the bacterial population reaches the carrying capacity, n(t) → K. If there is spacer loss (κ = 0), the spacer enhanced bacteria eventually disappear, so the steady state in this case is n 0 = n = K, n 1 = 0, independently of initial conditions. If there is no spacer loss (κ = 0), the fraction of bacteria that are spacer enhanced stays constant as the bacteria grow to capacity.
We can use this result to understand what happens in the more general case when the viral population starts off non-zero but eventually dies out (v → 0). In this case we need to compute the viral extinction time t 0 = t eff such that v(t eff ) ∼ 0. The arguments above suggest that viral extinction can only happen if there is no spacer loss -this is because even an exponentially small number of viruses will be able to multiply if presented with wild-type bacteria. Assuming the spacer loss rate is zero, the fraction of the total bacterial population that contains spacers will stay approximately constant from the time of viral extinction.
We can also investigate what happens when the spacer enhanced growth rate differs from that of the wild type, but this requires numerical simulations (SI Figure 3 ). Just like in the case when the growth rates are equal, the population of spacer-enhanced bacteria n 1 (t) decays exponentially to zero at large times.
In summary, when bacteria can lose spacers and the failure probability is lower than the critical value from eq. (9), virus and bacteria co-exist in a steady state after the initial transient dynamics.
III. DETAILED STEADY STATE SOLUTION FOR MULTIPLE SPACERS
In the main text, we showed the steady state values for the case of multiple spacers only when all the growth rates were the same. Here we generalize the dynamics from eq. [6] in the main text to the case where each spacer (i) has a different growth rate f i ,
n i − gvn 0 , ∂ t n i = f i 1 − n K n i − κn i − η i gvn i + α i µI 0 , ∂ t I 0 = gvn 0 − µI 0 , ∂ t I i = η i gvn i − µI i ,
Setting the time derivatives to zero, we obtain I 0 = g µ vn 0 ,
where the average failure probability (η) is defined as in the main text (eq. [8] ). Similar to the case of a single spacer, we see that the ratio between the total number of spacer enhanced bacteria and the number of wild type bacteria is independent of the growth rates (f i ). Figure 4 . Distribution of spacers as a function of failure probability (ηi) and acquisition probability (αi). The plot was obtained using eqs. (17) for a set of 100 spacers with failure probability below the critical value η < ηc and acquisition probabilities chosen uniformly in two different regimes. Panel a) First regime of small overall acquisition probability α = αi ≈ 0.1. As explained in the main text, this leads to a very homogenous population where the best spacers are more abundant. There is a strong dependence on the failure probability, which can be seen by the presence of closely spaced almost vertical contour lines. Panel b) Second regime of large overall acquisition probability, α ≈ 0.4. This tends to reduce the importance of differences in failure probability as shown by contour lines spaced far apart that bend horizontally.
By introducing the growth rate ratio (r i = f i /f 0 ) and the average growth rate ratio
we can now obtain the fraction of unused capacity (F r = 1 − n/K):
which generalizes eq. [8] in the main text. The remaining steady state values are given by:
Just as in the case when the growth rates are all equal (eq. [9] in the main text), the distribution of spacers shows a linear dependence on the acquisition probability α i . Figure 4 shows how the fraction of the bacterial population containing a specific spacer (n i /n) depends on that spacer's failure probability (η i ) and acquisition probability (α i ). This is shown for the case when all the growth rates are equal (r i = 1). Compare this to Fig. 4 in the main text, which gives a different way of looking at these results.
